Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) General Information

Description

A portfolio of subsidiaries and operations in Europe, Canada and all other markets outside of the U.S. The portfolio includes the ex-U.S. rights to commercialize obeticholic acid for primary biliary cholangitis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • New York, NY
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Advanz Pharma
Corporate Office
  • New York, NY
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets)‘s full profile, request access.

Request a free trial

Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets)‘s full profile, request access.

Request a free trial

Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) FAQs

  • Where is Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) headquartered?

    Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) is headquartered in New York, NY.

  • What industry is Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) in?

    Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets)’s primary industry is Buildings and Property.

  • Is Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) a private or public company?

    Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) is a Private company.

  • What is the current valuation of Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets)?

    The current valuation of Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) is .

  • What is Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets)’s current revenue?

    The current revenue for Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) is .

  • Who are Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets)’s investors?

    Intercept Pharmaceuticals has invested in Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets).

  • When was Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) acquired?

    Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) was acquired on 01-Jul-2022.

  • Who acquired Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets)?

    Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) was acquired by Advanz Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »